Literature DB >> 17643959

Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles.

P Bruno1, A Calastretti, M Priulla, L Asnaghi, F Scarlatti, A Nicolin, G Canti.   

Abstract

Akt activation assists tumor cell survival and promotes resistance to chemotherapy. Here we show that constitutively active Akt (CA-Akt) cells are highly sensitized to cell death induced by nutrient and growth factor deprivation, whereas dominant-negative Akt (DN-Akt) cells have a high rate of survival. The content of autophagosomes in starved CA-Akt cells was high, while DN-Akt cells expressed autophagic vacuoles constitutively, independently of nutrition conditions. Thus Akt down-regulation and downstream events can induce autophagosomes which were not directly determinants of cell death. Biochemical analysis in Akt-mutated cells show that (i) Akt and mTOR proteins were degraded more rapidly than the housekeeping proteins, (ii) mTOR phosphorylation at position Thr(2446) was relatively high in DN-Akt and low in CA-Akt cells, induced by starvation in mock cells only, which suggests reduced autoregulation of these pathways in Akt-mutated cells, (iii) both protein synthesis and protein degradation were significantly higher in starved CA-Akt cells than in starved DN-Akt cells or mock cells. In conclusion, constitutively active Akt, unable to control synthesis and wasting of proteins, accelerates the death of starved cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643959     DOI: 10.1016/j.cellsig.2007.06.008

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

Review 1.  The PI3K pathway in B cell metabolism.

Authors:  Julia Jellusova; Robert C Rickert
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-08-05       Impact factor: 8.250

2.  Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress.

Authors:  Rishi Raj Chhipa; Yue Wu; James L Mohler; Clement Ip
Journal:  Cell Signal       Date:  2010-06-04       Impact factor: 4.315

Review 3.  Cysteine/cystine redox signaling in cardiovascular disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2010-12-03       Impact factor: 7.376

4.  Tumor suppression by resistant maltodextrin, Fibersol-2.

Authors:  Eui Young So; Mutsuko Ouchi; Sara Cuesta-Sancho; Susan Losee Olson; Dirk Reif; Kazuhiro Shimomura; Toru Ouchi
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling.

Authors:  Hilary P Glazer; Robert M Osipov; Richard T Clements; Frank W Sellke; Cesario Bianchi
Journal:  Cell Cycle       Date:  2009-06-03       Impact factor: 4.534

Review 6.  Autophagy, redox signaling, and ventricular remodeling.

Authors:  Narasimman Gurusamy; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 7.  The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.

Authors:  Elizabeth A Mazzio; Fran Close; Karam F A Soliman
Journal:  Int J Mol Sci       Date:  2011-01-17       Impact factor: 5.923

8.  Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments.

Authors:  Francesc X Guix; Ragna Sannerud; Fedor Berditchevski; Amaia M Arranz; Katrien Horré; An Snellinx; Amantha Thathiah; Takaomi Saido; Takashi Saito; Sundaresan Rajesh; Michael Overduin; Samir Kumar-Singh; Enrico Radaelli; Nikky Corthout; Julien Colombelli; Sébastien Tosi; Sebastian Munck; Isabel H Salas; Wim Annaert; Bart De Strooper
Journal:  Mol Neurodegener       Date:  2017-03-10       Impact factor: 14.195

9.  Proliferation of Toxoplasma gondii suppresses host cell autophagy.

Authors:  Youn-Jin Lee; Hyun-Ouk Song; Young-Ha Lee; Jae-Sook Ryu; Myoung-Hee Ahn
Journal:  Korean J Parasitol       Date:  2013-06-30       Impact factor: 1.341

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.